SeqOne is proud to join the BVDH Autumn Meeting 2026 in Berlin, connecting with German clinical geneticists and laboratory leaders to discuss the future of human genetics. 

We are showcasing how our end-to-end genomic analysis platform helps routine clinical labs navigate evolving health policies, streamline diagnostic workflows, and deliver rapid, high-confidence results.

Key Themes: 

  • Scalable Clinical Workflows: Streamlining routine NGS analysis and variant interpretation to help German laboratories meet growing diagnostic demand efficiently.
  • Policy & Reimbursement Readiness: Supporting clinical practices with adaptable, IVD-compliant bioinformatic pipelines designed to fit evolving European regulatory and reimbursement frameworks.
  • Precision Diagnostics in Practice: Enabling precise, actionable reporting across rare diseases and inherited conditions to support high-quality, personalized patient care.
  • Collaborative Healthcare Engagement: Exchanging insights with medical geneticists and practice directors to align SeqOne’s software innovation with real-world laboratory needs.

‍

🧬 Experience the platform at BVDH

  • One NGS Platform, Built for Scale: End-to-end interpretation workflow with broad wet lab and sequencer compatibility.
  • AI Precision for Clinical Workflows: Built for real-world labs, SeqOne delivers fast, actionable insights, helping your team spend less time on variant interpretation and more time on confident clinical decisions.
  • Evaluate SeqOne for yourself: Visit our booth to explore our latest resources and learn how to start a free 30-day trial using your own data.

‍

👋 Meet the SeqOne Team

In town for the event? Let's connect! We’re booking 1-on-1 sessions to discuss whatever is top of mind for your team, from scientific collaborations and business inquiries to live walkthroughs of our NGS platform.

‍

Christophe Meynier
VP Global Sales

‍

Tony Fritz
Account Executive, DACH

‍

Katharina Collins
Field Application Specialist, DACH

‍